NDC 17856-0120-2 - CaroSpir

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
17856-0120
Requested NDC
17856-0120-2
Package NDCs from labels
17856-0120-2, 17856-0120-1
Manufacturer
ATLANTIC BIOLOGICALS CORP.
Effective date
2024-04-12
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
CaroSpir - ATLANTIC BIOLOGICALS CORP.ATLANTIC BIOLOGICALS CORP.2024-04-12HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
EffectiveRelated label
2024-04-12These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2024-01-30These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2022-03-11These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2022-01-28These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2020-05-20These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2020-01-31These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17856-0120-1CaroSpir72 in 1 BOXSuspension724
17856-0120-2CaroSpir2.5 mL in 1 CUPSuspension2.54

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17856-0120CAROSPIR SUSPENSION [ATLANTIC BIOLOGICALS CORP.]4Legacy NDC, 2 package rows20240415_07504afc-f0b6-40f6-8719-cd1c3e67fc35.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 71 of 71 · 1,403 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AntacidALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE AND SIMETHICONESafewayd36b56a4-06f0-47ff-8add-4c327d60be222016-01-21WarningsExact identifier
unii: 92RU3N3Y1O
Gas ReliefSIMETHICONESafeway14a9fb00-707a-4b55-a060-82ad53a806e32016-01-08WarningsExact identifier
unii: 92RU3N3Y1O
CPDA-1ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINEFenwal, Inc.051f7347-5a76-4664-8fe2-e61b3dfcb0e42014-08-27Exact identifier
unii: XF417D3PSL
unii: B22547B95K

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.